D'Mello SR, Borodezt K, Soltoff SP (1997) Insulin-like growth factor and potassium depolarization maintain neuronal survival by distinct pathways: possible involvement of PI 3-kinase in IGF-1 signaling. J Neurosci 17: 1548-1560
D'Souza DC, Kosten TR (2001) Cannabinoid antagonists: a treatment in search of an illness. Arch Gen Psychiatry 58: 330-331
D OG, Ireland D, Bord S, Compston JE (2004) Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor alpha, interleukin 1, and receptor activator of nuclear factor kappaB ligand (RANKL) regulate osteoclasts. Ann Rheum Dis 63: 354-359
Da S, Takahashi RN (2002) SR 141716A prevents delta 9-tetrahydrocannabinol-induced spatial learning deficit in a Morris-type water maze in mice. Prog Neuropsychopharmacol Biol Psychiatry 26: 321-325
da Silva AM, Klein C (1990) A rapid posttranslational myristylation of a 68-kD protein in D. discoideum. J Cell Biol 111: 401-407
Daaka Y, Friedman H, Klein TW (1996) Cannabinoid receptor proteins are increased in Jurkat, human T-cell line after mitogen activation. J Pharmacol Exp Ther 276: 776-783
Daaka Y, Zhu W, Friedman H, Klein TW (1997) Induction of interleukin-2 receptor alpha gene by delta9-tetrahydrocannabinol is mediated by nuclear factor kappaB and CB1 cannabinoid receptor. DNA Cell Biol 16: 301-309
Dal Santo P, Logan MA, Chisholm AD, Jorgensen EM (1999) The inositol trisphosphate receptor regulates a 50-second behavioral rhythm in C. elegans. Cell 98: 757-767
Dalley JW, Chudasama Y, Theobald DE, Pettifer CL, Fletcher CM, Robbins TW (2002) Nucleus accumbens dopamine and discriminated approach learning: interactive effects of 6-hydroxydopamine lesions and systemic apomorphine administration. Psychopharmacology (Berl) 161: 425-433
Dalley JW, Theobald DE, Bouger P, Chudasama Y, Cardinal RN, Robbins TW (2004) Cortical Cholinergic Function and Deficits in Visual Attentional Performance in Rats Following 192 IgG-Saporin-induced Lesions of the Medial Prefrontal Cortex. Cereb Cortex
Dallman MF (2003) Fast glucocorticoid feedback favors 'the munchies'. Trends in Endocrinology and Metabolism 14: 394-396
Daniel H, Crepel F (2001) Control of Ca(2+) influx by cannabinoid and metabotropic glutamate receptors in rat cerebellar cortex requires K(+) channels. J Physiol 537: 793-800
Daniel H, Levenes C, Fagni L, Conquet F, Bockaert J, Crepel F (1999) Inositol-1,4,5-trisphosphate-mediated rescue of cerebellar long-term depression in subtype 1 metabotropic glutamate receptor mutant mouse. Neuroscience 92: 1-6
Daniel H, Rancillac A, Crepel F (2004) Mechanisms underlying cannabinoid inhibition of presynaptic Ca2+ influx at parallel fibre synapses of the rat cerebellum. J Physiol 557: 159-174
Daniels M, Brown DR (2001) Astrocytes regulate N-methyl-D-aspartate receptor subunit composition increasing neuronal sensitivity to excitotoxicity. J Biol Chem 276: 22446-22452
Darmani NA (2001) The cannabinoid CB1 receptor antagonist SR 141716A reverses the antiemetic and motor depressant actions of WIN 55, 212-2. Eur J Pharmacol 430: 49-58
Darmani NA (2002) The potent emetogenic effects of the endocannabinoid, 2-AG (2-arachidonoylglycerol) are blocked by delta(9)-tetrahydrocannabinol and other cannnabinoids. J Pharmacol Exp Ther 300: 34-42
Darmani NA, Janoyan JJ, Kumar N, Crim JL (2003) Behaviorally active doses of the CB1 receptor antagonist SR 141716A increase brain serotonin and dopamine levels and turnover. Pharmacol Biochem Behav 75: 777-787
Darmani NA, Pandya DK (2000) Involvement of other neurotransmitters in behaviors induced by the cannabinoid CB1 receptor antagonist SR 141716A in naive mice. J Neural Transm 107: 931-945
Darmani NA, Sim-Selley LJ, Martin BR, Janoyan JJ, Crim JL, Parekh B, Breivogel CS (2003) Antiemetic and motor-depressive actions of CP55,940: cannabinoid CB1 receptor characterization, distribution, and G-protein activation. Eur J Pharmacol 459: 83-95
Dartt DA (1989) Signal transduction and control of lacrimal gland protein secretion: a review. Curr Eye Res 8: 619-636
Dartt DA (1994) Regulation of tear secretion. Adv Exp Med Biol 350: 1-9
Dartt DA, Baker AK, Rose PE, Murphy SA, Ronco LV, Unser MF (1988) Role of cyclic AMP and Ca2+ in potentiation of rat lacrimal gland protein secretion. Invest Ophthalmol Vis Sci 29: 1732-1738
Dartt DA, Dicker DM, Ronco LV, Kjeldsen IM, Hodges RR, Murphy SA (1990) Lacrimal gland inositol trisphosphate isomer and inositol tetrakisphosphate production. Am J Physiol 259: G274-281
Dartt DA, Donowitz M, Joshi VJ, Mathieu RS, Sharp GW (1984) Cyclic nucleotide-dependent enzyme secretion in the rat lacrimal gland. J Physiol 352: 375-384
Dartt DA, Guerina VJ, Donowitz M, Taylor L, Sharp GW (1982) Ca2+- and calmodulin-dependent protein phosphorylation in rat lacrimal gland. Biochem J 202: 799-802
Dartt DA, Hodges RR, Zoukhri D, Mircheff AK (1996) Protein phosphorylation in Golgi, endosomal, and endoplasmic reticulum membrane fractions of lacrimal gland. Curr Eye Res 15: 157-164
Dartt DA, Mircheff AK, Donowitz M, Sharp GW (1988) Ca2+ - and cAMP-induced protein phosphorylation in lacrimal gland basolateral membranes. Am J Physiol 254: G543-551
Dartt DA, Rose PE, Joshi VM, Donowitz M, Sharp GW (1985) Role of calcium in cholinergic stimulation of lacrimal gland protein secretion. Curr Eye Res 4: 475-483
Das SK, Paria BC, Chakraborty I, Dey SK (1995) Cannabinoid ligand-receptor signaling in the mouse uterus. Proc Natl Acad Sci U S A 92: 4332-4336
Davenport AP, Battistini B (2002) Classification of endothelin receptors and antagonists in clinical development. Clin Sci (Lond) 103 Suppl 48: 1S-3S
Davenport R (2002) Glutamate receptors in plants. Ann Bot (Lond) 90: 549-557
David T, Thomas C, Zaccone P, Dunne DW, Cooke A (2004) The impact of infection on the incidence of autoimmune disease. Curr Top Med Chem 4: 521-529
Davies SN, Pertwee RG, Riedel G (2002) Functions of cannabinoid receptors in the hippocampus. Neuropharmacology 42: 993-1007
Davis JB, Gray J, Gunthorpe MJ, Hatcher JP, Davey PT, Overend P, Harries MH, Latcham J, Clapham C, Atkinson K, Hughes SA, Rance K, Grau E, Harper AJ, Pugh PL, Rogers DC, Bingham S, Randall A, Sheardown SA (2000) Vanilloid receptor-1 is essential for inflammatory thermal hyperalgesia. Nature 405: 183-187
Davis MI, Ronesi J, Lovinger DM (2003) A predominant role for inhibition of the adenylate cyclase/protein kinase A pathway in ERK activation by cannabinoid receptor 1 in N1E-115 neuroblastoma cells. J Biol Chem 278: 48973-48980
Davis RJ (1995) Transcriptional regulation by MAP kinases. Mol Reprod Dev 42: 459-467
Day TA, Rakhshan F, Deutsch DG, Barker EL (2001) Role of fatty acid amide hydrolase in the transport of the endogenous cannabinoid anandamide. Mol Pharmacol 59: 1369-1375
de Bono B, Chothia C (2003) Exegesis: a procedure to improve gene predictions and its use to find immunoglobulin superfamily proteins in the human and mouse genomes. Nucleic Acids Res 31: 6096-6103
De Esch IJ, Mills JE, Perkins TD, Romeo G, Hoffmann M, Wieland K, Leurs R, Menge WM, Nederkoorn PH, Dean PM, Timmerman H (2001) Development of a pharmacophore model for histamine H3 receptor antagonists, using the newly developed molecular modeling program SLATE. J Med Chem 44: 1666-1674
De Lago E, De Miguel R, Lastres-Becker I, Ramos JA, Fernandez-Ruiz J (2004) Involvement of vanilloid-like receptors in the effects of anandamide on motor behavior and nigrostriatal dopaminergic activity: in vivo and in vitro evidence. Brain Res 1007: 152-159
de Lago E, Fernandez-Ruiz J, Ortega-Gutierrez S, Viso A, Lopez-Rodriguez ML, Ramos JA (2002) UCM707, a potent and selective inhibitor of endocannabinoid uptake, potentiates hypokinetic and antinociceptive effects of anandamide. Eur J Pharmacol 449: 99-103
de Lago E, Ligresti A, Ortar G, Morera E, Cabranes A, Pryce G, Bifulco M, Baker D, Fernandez-Ruiz J, Di Marzo V (2004) In vivo pharmacological actions of two novel inhibitors of anandamide cellular uptake. Eur J Pharmacol 484: 249-257
De Marchi N, De Petrocellis L, Orlando P, Daniele F, Fezza F, Di Marzo V (2003) Endocannabinoid signalling in the blood of patients with schizophrenia. Lipids Health Dis 2: 5
de Miguel R, Romero J, Munoz RM, Garcia-Gil L, Gonzalez S, Villanua MA, Makriyannis A, Ramos JA, Fernandez-Ruiz JJ (1998) Effects of cannabinoids on prolactin and gonadotrophin secretion: involvement of changes in hypothalamic gamma-aminobutyric acid (GABA) inputs. Biochem Pharmacol 56: 1331-1338
De Petrocellis L, Bisogno T, Davis JB, Pertwee RG, Di Marzo V (2000) Overlap between the ligand recognition properties of the anandamide transporter and the VR1 vanilloid receptor: inhibitors of anandamide uptake with negligible capsaicin-like activity. FEBS Lett 483: 52-56
De Petrocellis L, Bisogno T, Ligresti A, Bifulco M, Melck D, Di Marzo V (2002) Effect on cancer cell proliferation of palmitoylethanolamide, a fatty acid amide interacting with both the cannabinoid and vanilloid signalling systems. Fundam Clin Pharmacol 16: 297-302
De Petrocellis L, Bisogno T, Maccarrone M, Davis JB, Finazzi-Agro A, Di Marzo V (2001) The activity of anandamide at vanilloid VR1 receptors requires facilitated transport across the cell membrane and is limited by intracellular metabolism. J Biol Chem 276: 12856-12863
De Petrocellis L, Cascio MG, Di Marzo V (2004) The endocannabinoid system: a general view and latest additions. Br J Pharmacol 141: 765-774
De Petrocellis L, Davis JB, Di Marzo V (2001) Palmitoylethanolamide enhances anandamide stimulation of human vanilloid VR1 receptors. FEBS Lett 506: 253-256
De Petrocellis L, Harrison S, Bisogno T, Tognetto M, Brandi I, Smith GD, Creminon C, Davis JB, Geppetti P, Di Marzo V (2001) The vanilloid receptor (VR1)-mediated effects of anandamide are potently enhanced by the cAMP-dependent protein kinase. J Neurochem 77: 1660-1663
De Petrocellis L, Melck D, Bisogno T, Di Marzo V (2000) Endocannabinoids and fatty acid amides in cancer, inflammation and related disorders. Chem Phys Lipids 108: 191-209
De Petrocellis L, Melck D, Bisogno T, Milone A, Di Marzo V (1999) Finding of the endocannabinoid signalling system in Hydra, a very primitive organism: possible role in the feeding response. Neuroscience 92: 377-387
De Petrocellis L, Melck D, Palmisano A, Bisogno T, Laezza C, Bifulco M, Di Marzo V (1998) The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc Natl Acad Sci U S A 95: 8375-8380
De Petrocellis L, Melck D, Ueda N, Kurahashi Y, Bisogno T, Yamamoto S, Di Marzo V (1997) Brain and peripheral anandamide amidohydrolase and its inhibition by synthetic arachidonate analogues. Adv Exp Med Biol 433: 259-263
De Petrocellis L, Melck D, Ueda N, Maurelli S, Kurahashi Y, Yamamoto S, Marino G, Di Marzo V (1997) Novel inhibitors of brain, neuronal, and basophilic anandamide amidohydrolase. Biochem Biophys Res Commun 231: 82-88
De Petrocellis L, Orlando P, Di Marzo V (1995) Anandamide, an endogenous cannabinomimetic substance, modulates rat brain protein kinase C in vitro. Biochem Mol Biol Int 36: 1127-1133
De Vries TJ, Homberg JR, Binnekade R, Raaso H, Schoffelmeer AN (2003) Cannabinoid modulation of the reinforcing and motivational properties of heroin and heroin-associated cues in rats. Psychopharmacology (Berl) 168: 164-169
De Vries TJ, Shaham Y, Homberg JR, Crombag H, Schuurman K, Dieben J, Vanderschuren LJ, Schoffelmeer AN (2001) A cannabinoid mechanism in relapse to cocaine seeking. Nat Med 7: 1151-1154
De Vry J, Jentzsch KR (2003) Intrinsic activity estimation of cannabinoid CB1 receptor ligands in a drug discrimination paradigm. Behav Pharmacol 14: 471-476
De Vry J, Jentzsch KR (2004) Partial agonist-like profile of the cannabinoid receptor antagonist SR141716A in a food-reinforced operant paradigm. Behav Pharmacol 15: 13-20
De Vry J, Jentzsch KR, Kuhl E, Eckel G (2004) Behavioral effects of cannabinoids show differential sensitivity to cannabinoid receptor blockade and tolerance development. Behav Pharmacol 15: 1-12
de Wildt RM, Tomlinson IM, Ong JL, Holliger P (2002) Isolation of receptor-ligand pairs by capture of long-lived multivalent interaction complexes. Proc Natl Acad Sci U S A 99: 8530-8535
de Wildt RM, van Venrooij WJ, Winter G, Hoet RM, Tomlinson IM (1999) Somatic insertions and deletions shape the human antibody repertoire. J Mol Biol 294: 701-710
Deak E, Szabo I, Kalmaczhelyi A, Gal Z, Barabas G, Penyige A (1998) Membrane-bound and extracellular beta-lactamase production with developmental regulation in Streptomyces griseus NRRL B-2682. Microbiology 144 (Pt 8): 2169-2177
Dean W, Bowden L, Aitchison A, Klose J, Moore T, Meneses JJ, Reik W, Feil R (1998) Altered imprinted gene methylation and expression in completely ES cell-derived mouse fetuses: association with aberrant phenotypes. Development 125: 2273-2282
Deane CM, Lummis SC (2001) The role and predicted propensity of conserved proline residues in the 5-HT3 receptor. J Biol Chem 276: 37962-37966
Del Arco I, Navarro M, Bilbao A, Ferrer B, Piomelli D, Rodriguez De Fonseca F (2002) Attenuation of spontaneous opiate withdrawal in mice by the anandamide transport inhibitor AM404. Eur J Pharmacol 454: 103-104
del Carmen Garcia M, Adler-Graschinsky E, Celuch SM (2003) Hypotensive effect of anandamide through the activation of CB1 and VR1 spinal receptors in urethane-anesthetized rats. Naunyn Schmiedebergs Arch Pharmacol 368: 270-276
Delatte MS, Winsauer PJ, Moerschbaecher JM (2002) Tolerance to the disruptive effects of Delta(9)-THC on learning in rats. Pharmacol Biochem Behav 74: 129-140
Dennedy MC, Friel AM, Houlihan DD, Broderick VM, Smith T, Morrison JJ (2004) Cannabinoids and the human uterus during pregnancy. Am J Obstet Gynecol 190: 2-9; discussion 3A
Derbyshire DJ, Ellar DJ, Li J (2001) Crystallization of the Bacillus thuringiensis toxin Cry1Ac and its complex with the receptor ligand N-acetyl-D-galactosamine. Acta Crystallogr D Biol Crystallogr 57: 1938-1944
Derkinderen P, Ledent C, Parmentier M, Girault JA (2001) Cannabinoids activate p38 mitogen-activated protein kinases through CB1 receptors in hippocampus. J Neurochem 77: 957-960
Derkinderen P, Toutant M, Burgaya F, Le Bert M, Siciliano JC, de Franciscis V, Gelman M, Girault JA (1996) Regulation of a neuronal form of focal adhesion kinase by anandamide. Science 273: 1719-1722
Derkinderen P, Toutant M, Kadare G, Ledent C, Parmentier M, Girault JA (2001) Dual role of Fyn in the regulation of FAK+6,7 by cannabinoids in hippocampus. J Biol Chem 276: 38289-38296
Derkinderen P, Valjent E, Toutant M, Corvol JC, Enslen H, Ledent C, Trzaskos J, Caboche J, Girault JA (2003) Regulation of extracellular signal-regulated kinase by cannabinoids in hippocampus. J Neurosci 23: 2371-2382
Deroche-Gamonet V, Le Moal M, Piazza PV, Soubrie P (2001) SR141716, a CB1 receptor antagonist, decreases the sensitivity to the reinforcing effects of electrical brain stimulation in rats. Psychopharmacology (Berl) 157: 254-259
Derocq JM, Bouaboula M, Marchand J, Rinaldi-Carmona M, Segui M, Casellas P (1998) The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines. FEBS Lett 425: 419-425
Derocq JM, Jbilo O, Bouaboula M, Segui M, Clere C, Casellas P (2000) Genomic and functional changes induced by the activation of the peripheral cannabinoid receptor CB2 in the promyelocytic cells HL-60. Possible involvement of the CB2 receptor in cell differentiation. J Biol Chem 275: 15621-15628
Derocq JM, Segui M, Marchand J, Le Fur G, Casellas P (1995) Cannabinoids enhance human B-cell growth at low nanomolar concentrations. FEBS Lett 369: 177-182
Desarnaud F, Cadas H, Piomelli D (1995) Anandamide amidohydrolase activity in rat brain microsomes. Identification and partial characterization. J Biol Chem 270: 6030-6035
Desbordes SC, Sanson B (2003) The glypican Dally-like is required for Hedgehog signalling in the embryonic epidermis of Drosophila. Development 130: 6245-6255
Desdouits-Magnen J, Desdouits F, Takeda S, Syu LJ, Saltiel AR, Buxbaum JD, Czernik AJ, Nairn AC, Greengard P (1998) Regulation of secretion of Alzheimer amyloid precursor protein by the mitogen-activated protein kinase cascade. J Neurochem 70: 524-530
Desire L, Courtois Y, Jeanny JC (2000) Endogenous and exogenous fibroblast growth factor 2 support survival of chick retinal neurons by control of neuronal neuronal bcl-x(L) and bcl-2 expression through a fibroblast berowth factor receptor 1- and ERK-dependent pathway. J Neurochem 75: 151-163
Deusch E, Kraft B, Nahlik G, Weigl L, Hohenegger M, Kress HG (2003) No evidence for direct modulatory effects of delta 9-tetrahydrocannabinol on human polymorphonuclear leukocytes. J Neuroimmunol 141: 99-103
Deutsch DG, Chin SA (1993) Enzymatic synthesis and degradation of anandamide, a cannabinoid receptor agonist. Biochem Pharmacol 46: 791-796
Deutsch DG, Glaser ST, Howell JM, Kunz JS, Puffenbarger RA, Hillard CJ, Abumrad N (2001) The cellular uptake of anandamide is coupled to its breakdown by fatty-acid amide hydrolase. J Biol Chem 276: 6967-6973
Deutsch DG, Goligorsky MS, Schmid PC, Krebsbach RJ, Schmid HH, Das SK, Dey SK, Arreaza G, Thorup C, Stefano G, Moore LC (1997) Production and physiological actions of anandamide in the vasculature of the rat kidney. J Clin Invest 100: 1538-1546
Deutsch DG, Lin S, Hill WA, Morse KL, Salehani D, Arreaza G, Omeir RL, Makriyannis A (1997) Fatty acid sulfonyl fluorides inhibit anandamide metabolism and bind to the cannabinoid receptor. Biochem Biophys Res Commun 231: 217-221
Deutsch DG, Makriyannis A (1997) Inhibitors of anandamide breakdown. NIDA Res Monogr 173: 65-84
Deutsch DG, Omeir R, Arreaza G, Salehani D, Prestwich GD, Huang Z, Howlett A (1997) Methyl arachidonyl fluorophosphonate: a potent irreversible inhibitor of anandamide amidase. Biochem Pharmacol 53: 255-260
Deutsch DG, Ueda N, Yamamoto S (2002) The fatty acid amide hydrolase (FAAH). Prostaglandins Leukot Essent Fatty Acids 66: 201-210
Devane WA (1994) New dawn of cannabinoid pharmacology. Trends Pharmacol Sci 15: 40-41
Devane WA, Axelrod J (1994) Enzymatic synthesis of anandamide, an endogenous ligand for the cannabinoid receptor, by brain membranes. Proc Natl Acad Sci U S A 91: 6698-6701
Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G, Gibson D, Mandelbaum A, Etinger A, Mechoulam R (1992) Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949
Devlin MG, Christopoulos A (2002) Modulation of cannabinoid agonist binding by 5-HT in the rat cerebellum. J Neurochem 80: 1095-1102
Dhandapani KM, Brann DW (2002) Protective effects of estrogen and selective estrogen receptor modulators in the brain. Biol Reprod 67: 1379-1385
Dhillo WS, Bloom SR (2001) Hypothalamic peptides as drug targets for obesity. Curr Opin Pharmacol 1: 651-655
Di Carlo G, Izzo AA (2003) Cannabinoids for gastrointestinal diseases: potential therapeutic applications. Expert Opin Investig Drugs 12: 39-49
Di Ciano P, Cardinal RN, Cowell RA, Little SJ, Everitt BJ (2001) Differential involvement of NMDA, AMPA/kainate, and dopamine receptors in the nucleus accumbens core in the acquisition and performance of pavlovian approach behavior. J Neurosci 21: 9471-9477
Di Ciano P, Everitt BJ (2001) Dissociable effects of antagonism of NMDA and AMPA/KA receptors in the nucleus accumbens core and shell on cocaine-seeking behavior. Neuropsychopharmacology 25: 341-360
Di Ciano P, Everitt BJ (2003) The GABA(B) receptor agonist baclofen attenuates cocaine- and heroin-seeking behavior by rats. Neuropsychopharmacology 28: 510-518
Di Ciano P, Everitt BJ (2004) Contribution of the ventral tegmental area to cocaine-seeking maintained by a drug-paired conditioned stimulus in rats. Eur J Neurosci 19: 1661-1667
Di Filippo C, Rossi F, Rossi S, D'Amico M (2004) Cannabinoid CB2 receptor activation reduces mouse myocardial ischemia-reperfusion injury: involvement of cytokine/chemokines and PMN. J Leukoc Biol 75: 453-459
Di M, Bisogno T, De Petrocellis L (2000) Endocannabinoids: new targets for drug development. Curr Pharm Des 6: 1361-1380
Di Marzo V (1998) 2-Arachidonoyl-glycerol as an "endocannabinoid": limelight for a formerly neglected metabolite. Biochemistry (Mosc) 63: 13-21
Di Marzo V (1998) 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: biochemistry and possible physiopathological relevance. Biochim Biophys Acta 1392: 153-175
Di Marzo V (1999) Biosynthesis and inactivation of endocannabinoids: relevance to their proposed role as neuromodulators. Life Sci 65: 645-655
Di Marzo V (2000) Regulation of endocannabinoid levels under physiological and pathological conditions. A mini-review. Pharmacy and Pharmacology Communications 6: 235-241
Di Marzo V (2002) Endocannabinoids in the new millennium. Prostaglandins Leukot Essent Fatty Acids 66: 91-92
Di Marzo V (2003) Manipulation of the endocannabinoid system by a general anaesthetic. Br J Pharmacol 139: 885-886
Di Marzo V, Berrendero F, Bisogno T, Gonzalez S, Cavaliere P, Romero J, Cebeira M, Ramos JA, Fernandez-Ruiz JJ (2000) Enhancement of anandamide formation in the limbic forebrain and reduction of endocannabinoid contents in the striatum of delta9-tetrahydrocannabinol-tolerant rats. J Neurochem 74: 1627-1635
Di Marzo V, Bifulco M, De Petrocellis L (2000) Endocannabinoids and multiple sclerosis: a blessing from the 'inner bliss'? Trends Pharmacol Sci 21: 195-197
Di Marzo V, Bisogno T, De Petrocellis L (2001) Anandamide: some like it hot. Trends Pharmacol Sci 22: 346-349
Di Marzo V, Bisogno T, De Petrocellis L, Brandi I, Jefferson RG, Winckler RL, Davis JB, Dasse O, Mahadevan A, Razdan RK, Martin BR (2001) Highly selective CB(1) cannabinoid receptor ligands and novel CB(1)/VR(1) vanilloid receptor "hybrid" ligands. Biochem Biophys Res Commun 281: 444-451
Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Martin BR (1999) Cannabimimetic fatty acid derivatives: the anandamide family and other endocannabinoids. Curr Med Chem 6: 721-744
Di Marzo V, Bisogno T, De Petrocellis L, Melck D, Orlando P, Wagner JA, Kunos G (1999) Biosynthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in circulating and tumoral macrophages. Eur J Biochem 264: 258-267
Di Marzo V, Bisogno T, Melck D, Ross R, Brockie H, Stevenson L, Pertwee R, De Petrocellis L (1998) Interactions between synthetic vanilloids and the endogenous cannabinoid system. FEBS Lett 436: 449-454
Di Marzo V, Bisogno T, Sugiura T, Melck D, De Petrocellis L (1998) The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal- and basophil-like cells: connections with anandamide. Biochem J 331 (Pt 1): 15-19
Di Marzo V, Bisogno T, Sugiura T, Melck D, De Petrocellis L (1998) The novel endogenous cannabinoid 2-arachidonoylglycerol is inactivated by neuronal and basophil-like cells: Connections with anandamide. Biochemical Journal 331: 15-19
Di Marzo V, Blumberg PM, Szallasi A (2002) Endovanilloid signaling in pain. Curr Opin Neurobiol 12: 372-379
Di Marzo V, Breivogel C, Bisogno T, Melck D, Patrick G, Tao Q, Szallasi A, Razdan RK, Martin BR (2000) Neurobehavioral activity in mice of N-vanillyl-arachidonyl-amide. Eur J Pharmacol 406: 363-374
Di Marzo V, Breivogel CS, Tao Q, Bridgen DT, Razdan RK, Zimmer AM, Zimmer A, Martin BR (2000) Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J Neurochem 75: 2434-2444
Di Marzo V, De Petrocellis L, Bisogno T, Maurelli S (1997) The endogenous cannabimimetic eicosanoid, anandamide, induces arachidonate release in J774 mouse macrophages. Adv Exp Med Biol 407: 341-346
Di Marzo V, De Petrocellis L, Bisogno T, Melck D (1999) Metabolism of anandamide and 2-arachidonoylglycerol: an historical overview and some recent developments. Lipids 34 Suppl: S319-325
Di Marzo V, De Petrocellis L, Fezza F, Ligresti A, Bisogno T (2002) Anandamide receptors. Prostaglandins Leukot Essent Fatty Acids 66: 377-391
Di Marzo V, De Petrocellis L, Sepe N, Buono A (1996) Biosynthesis of anandamide and related acylethanolamides in mouse J774 macrophages and N18 neuroblastoma cells. Biochem J 316 (Pt 3): 977-984
Di Marzo V, De Petrocellis L, Sugiura T, Waku K (1996) Potential biosynthetic connections between the two cannabimimetic eicosanoids, anandamide and 2-arachidonoyl-glycerol, in mouse neuroblastoma cells. Biochem Biophys Res Commun 227: 281-288
Di Marzo V, Deutsch DG (1998) Biochemistry of the endogenous ligands of cannabinoid receptors. Neurobiol Dis 5: 386-404
Di Marzo V, Fontana A (1995) Anandamide, an endogenous cannabinomimetic eicosanoid: 'killing two birds with one stone'. Prostaglandins Leukot Essent Fatty Acids 53: 1-11
Di Marzo V, Fontana A, Cadas H, Schinelli S, Cimino G, Schwartz JC, Piomelli D (1994) Formation and inactivation of endogenous cannabinoid anandamide in central neurons. Nature 372: 686-691
Di Marzo V, Goparaju SK, Wang L, Liu J, Batkai S, Jarai Z, Fezza F, Miura GI, Palmiter RD, Sugiura T, Kunos G (2001) Leptin-regulated endocannabinoids are involved in maintaining food intake. Nature 410: 822-825
Di Marzo V, Griffin G, De Petrocellis L, Brandi I, Bisogno T, Williams W, Grier MC, Kulasegram S, Mahadevan A, Razdan RK, Martin BR (2002) A structure/activity relationship study on arvanil, an endocannabinoid and vanilloid hybrid. J Pharmacol Exp Ther 300: 984-991
Di Marzo V, Hill MP, Bisogno T, Crossman AR, Brotchie JM (2000) Enhanced levels of endogenous cannabinoids in the globus pallidus are associated with a reduction in movement in an animal model of Parkinson's disease. Faseb J 14: 1432-1438
Di Marzo V, Lastres-Becker I, Bisogno T, De Petrocellis L, Milone A, Davis JB, Fernandez-Ruiz JJ (2001) Hypolocomotor effects in rats of capsaicin and two long chain capsaicin homologues. Eur J Pharmacol 420: 123-131
Di Marzo V, Melck D, Bisogno T, De Petrocellis L (1998) Endocannabinoids: endogenous cannabinoid receptor ligands with neuromodulatory action. Trends Neurosci 21: 521-528
Di Marzo V, Melck D, De Petrocellis L, Bisogno T (2000) Cannabimimetic fatty acid derivatives in cancer and inflammation. Prostaglandins Other Lipid Mediat 61: 43-61
Di Marzo V, Melck D, Orlando P, Bisogno T, Zagoory O, Bifulco M, Vogel Z, De Petrocellis L (2001) Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. Biochem J 358: 249-255
Di Marzo V, Sepe N, De Petrocellis L, Berger A, Crozier G, Fride E, Mechoulam R (1998) Trick or treat from food endocannabinoids? Nature 396: 636-637
Di Marzo V, Sepe N, De Petrocellis L, Berger A, Crozier G, Fride E, Mechoulam R (1999) Endocannabinoid content of food: Levels and potential bioactivity. FASEB Journal 13
Di Marzo V, Yamamoto S (2000) Anandamide and other cannabimimetic fatty acid derivatives-foreword. Prostaglandins Other Lipid Mediat 61: 1-2
Di S, Halmos K, Tasker JG (2003) Cannabinoid regulation of synaptic inputs to hypothalamic neuroendocrine cells. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Di S, Malcher-Lopes R, Halmos KC, Tasker JG (2003) Nongenomic glucocorticoid inhibition via endocannabinoid release in the hypothalamus: a fast feedback mechanism. J Neurosci 23: 4850-4857
Di S, Tasker JG (2002) Rapid Glucocorticoid Effects on Glutamatergic Synaptic Activity Via Endocannabinoid Release from Hypothalamic Magnocellular Neurons. Society for Neuroscience Abstract Viewer and Itinerary Planner 2002
di Tomaso E, Beltramo M, Piomelli D (1996) Brain cannabinoids in chocolate. Nature 382: 677-678
Di Tomaso E, Cadas H, Gaillet S, Beltramo M, Desarnaud F, Venance L, Piomelli D (1997) Endogenous lipids that activate cannabinoid receptors. Formation and inactivation. Adv Exp Med Biol 407: 335-340
Dian EE, Chapman KD, Venables B, Gross GW (2003) Neuromodulatory effects of natural soy lecithin extracts: An in vitro assessment. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Diana MA, Marty A (2003) Biphasic retrograde control of interneuron firing rate by Purkinje cells. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Diana MA, Marty A (2004) Endocannabinoid-mediated short-term synaptic plasticity: depolarization-induced suppression of inhibition (DSI) and depolarization-induced suppression of excitation (DSE). Br J Pharmacol 142: 9-19
Dib K, Whitehead JP, Humphreys PJ, Soos MA, Baynes KC, Kumar S, Harvey T, O'Rahilly S (1998) Impaired activation of phosphoinositide 3-kinase by insulin in fibroblasts from patients with severe insulin resistance and pseudoacromegaly. A disorder characterized by selective postreceptor insulin resistance. J Clin Invest 101: 1111-1120
Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 99: 10819-10824
Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S, Piomelli D (2002) Brain monoglyceride lipase participating in endocannabinoid inactivation (vol 99, pg 10819, 2002). Proceedings of the National Academy of Sciences of the United States of America 99: 13961-13961
Dinh TP, Freund TF, Piomelli D (2002) A role for monoglyceride lipase in 2-arachidonoylglycerol inactivation. Chem Phys Lipids 121: 149-158
Dinh TP, Katona I, Leslie FM, Carpenter D, Zhou QY, Freund T, Piomelli D (2001) Hydrolysis of the endocannabinoid 2-arachidonylglycerol by a rat brain monoacylglycerol lipase. Society for Neuroscience Abstracts 27
Dinh TP, Leslie F, Zhou QY, Piomelli D (2000) Molecular characterization of a rat brain monoacylglycerol lipase that participates in the hydrolysis of the endocannabinoid 2-arachidonylglycerol. Society for Neuroscience Abstracts 26: Abstract No.-813.818
Djali PK, Singh J, Adeghate E (1996) Immunohistochemical study of leucine-enkephalin and its secretory effects in the isolated pig lacrimal gland. Graefes Arch Clin Exp Ophthalmol 234: 264-269
Dmitrieva N, Berkley KJ (2002) Contrasting effects of WIN 55212-2 on motility of the rat bladder and uterus. J Neurosci 22: 7147-7153
Dobbertin A, Rhodes KE, Garwood J, Properzi F, Heck N, Rogers JH, Fawcett JW, Faissner A (2003) Regulation of RPTPbeta/phosphacan expression and glycosaminoglycan epitopes in injured brain and cytokine-treated glia. Mol Cell Neurosci 24: 951-971
Dogrul A, Gardell LR, Ma S, Ossipov MH, Porreca F, Lai J (2002) 'Knock-down' of spinal CB1 receptors produces abnormal pain and elevates spinal dynorphin content in mice. Pain 100: 203-209
Dogulu FH, Ozogul C, Akpek S, Kurt G, Emmez H, Ercan S, Baykaner MK (2003) Intra-arterial simultaneous administration of anandamide attenuates endothelin-1 induced vasospasm in rabbit basilar arteries. Acta Neurochir (Wien) 145: 579-582
Doi M, Kondo Y, Tsutsumi K (2003) Lipoprotein lipase activator NO-1886 (ibrolipim) accelerates the mRNA expression of fatty acid oxidation-related enzymes in rat liver. Metabolism 52: 1547-1550
Domingo JC, Mora M, Africa de Madariaga M (1993) Incorporation of N-acylethanolamine phospholipids into egg phosphatidylcholine vesicles: characterization and permeability properties of the binary systems. Biochim Biophys Acta 1148: 308-316
Domingo JC, Mora M, Africa de Madariaga M (1994) Role of headgroup structure in the phase behaviour of N-acylethanolamine phospholipids: hydrogen-bonding ability and headgroup size. Chem Phys Lipids 69: 229-240
Dong H, Jiang Y, Cole WC, Triggle CR (2000) Comparison of the pharmacological properties of EDHF-mediated vasorelaxation in guinea-pig cerebral and mesenteric resistance vessels. Br J Pharmacol 130: 1983-1991
Dong H, O'Brien RJ, Fung ET, Lanahan AA, Worley PF, Huganir RL (1997) GRIP: a synaptic PDZ domain-containing protein that interacts with AMPA receptors. Nature 386: 279-284
Doody GM, Bell SE, Vigorito E, Clayton E, McAdam S, Tooze R, Fernandez C, Lee IJ, Turner M (2001) Signal transduction through Vav-2 participates in humoral immune responses and B cell maturation. Nat Immunol 2: 542-547
Doody GM, Billadeau DD, Clayton E, Hutchings A, Berland R, McAdam S, Leibson PJ, Turner M (2000) Vav-2 controls NFAT-dependent transcription in B- but not T-lymphocytes. Embo J 19: 6173-6184
Dornan S, Sebestyen Z, Gamble J, Nagy P, Bodnar A, Alldridge L, Doe S, Holmes N, Goff LK, Beverley P, Szollosi J, Alexander DR (2002) Differential association of CD45 isoforms with CD4 and CD8 regulates the actions of specific pools of p56lck tyrosine kinase in T cell antigen receptor signal transduction. J Biol Chem 277: 1912-1918
Dougalis A, Lees G (2002) Anandamide transport inhibition, but not inhibition of fatty acid amide hydrolase (FAAH) blocks the induction of long-term potentiation (LTP) in the CA1 neurons of the rat hippocampal slice. Journal of Physiology (Cambridge) 544P
Dougalis A, Lees G, Ganellin CR (2004) The sleep lipid oleamide may represent an endogenous anticonvulsant: an in vitro comparative study in the 4-aminopyridine rat brain-slice model. Neuropharmacology 46: 541-554
Downer E, Boland B, Fogarty M, Campbell V (2001) Delta 9-tetrahydrocannabinol induces the apoptotic pathway in cultured cortical neurones via activation of the CB1 receptor. Neuroreport 12: 3973-3978
Downer EJ, Fogarty MP, Campbell VA (2003) Tetrahydrocannabinol-induced neurotoxicity depends on CB1 receptor-mediated c-Jun N-terminal kinase activation in cultured cortical neurons. Br J Pharmacol 140: 547-557
Doyle JJ, Luckow MA (2003) The rest of the iceberg. Legume diversity and evolution in a phylogenetic context. Plant Physiol 131: 900-910
Drake DJ, Jensen RS, Busch-Petersen J, Kawakami JK, Concepcion Fernandez-Garcia M, Fan P, Makriyannis A, Tius MA (1998) Classical/nonclassical hybrid cannabinoids: southern aliphatic chain-functionalized C-6beta methyl, ethyl, and propyl analogues. J Med Chem 41: 3596-3608
Dreisbach RH, Gerlach E (1967) Adenosine phosphate of rat salivary and lacrimal glands in vitro. Proc Soc Exp Biol Med 126: 281-282
Drew LJ, Harris J, Millns PJ, Kendall DA, Chapman V (2000) Activation of spinal cannabinoid 1 receptors inhibits C-fibre driven hyperexcitable neuronal responses and increases [35S]GTPgammaS binding in the dorsal horn of the spinal cord of noninflamed and inflamed rats. Eur J Neurosci 12: 2079-2086
Drynan LF, Hamilton TL, Rabbitts TH (2001) T cell tumorigenesis in Lmo2 transgenic mice is independent of V-D-J recombinase activity. Oncogene 20: 4412-4415
Drysdale AJ, Platt B (2003) Cannabinoids: mechanisms and therapeutic applications in the CNS. Curr Med Chem 10: 2719-2732
Duarte C, Alonso R, Bichet N, Cohen C, Soubrie P, Thiebot MH (2004) Blockade by the cannabinoid CB1 receptor antagonist, rimonabant (SR141716), of the potentiation by quinelorane of food-primed reinstatement of food-seeking behavior. Neuropsychopharmacology 29: 911-920
Dubal DB, Kashon ML, Pettigrew LC, Ren JM, Finklestein SP, Rau SW, Wise PM (1998) Estradiol protects against ischemic injury. J Cereb Blood Flow Metab 18: 1253-1258
Dubal DB, Zhu H, Yu J, Rau SW, Shughrue PJ, Merchenthaler I, Kindy MS, Wise PM (2001) Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A 98: 1952-1957
Dudek H, Datta SR, Franke TF, Birnbaum MJ, Yao R, Cooper GM, Segal RA, Kaplan DR, Greenberg ME (1997) Regulation of neuronal survival by the serine-threonine protein kinase Akt. Science 275: 661-665
Duguid IC, Smart TG (2003) Retrograde release of glutamate drives endocannabinoid release during DSI. Society for Neuroscience Abstract Viewer and Itinerary Planner 2003
Duncan M, Kendall DA, Ralevic V (2002) The endocannabinoid noladin ether attenuates sensory neurotransmission in the rat isolated mesenteric arterial bed. British Journal of Pharmacology 136
Dunning AM, McBride S, Gregory J, Durocher F, Foster NA, Healey CS, Smith N, Pharoah PD, Luben RN, Easton DF, Ponder BA (1999) No association between androgen or vitamin D receptor gene polymorphisms and risk of breast cancer. Carcinogenesis 20: 2131-2135
Duran M, Laporte JR, Capella D (2004) [News about therapeutic use of Cannabis and endocannabinoid system]. Med Clin (Barc) 122: 390-398
Durbeej M, Henry MD, Campbell KP (1998) Dystroglycan in development and disease. Curr Opin Cell Biol 10: 594-601
Dutta AK, Ryan W, Thomas BF, Singer M, Compton DR, Martin BR, Razdan RK (1997) Synthesis, pharmacology, and molecular modeling of novel 4-alkyloxy indole derivatives related to cannabimimetic aminoalkyl indoles (AAIs). Bioorg Med Chem 5: 1591-1600
Duvoisin RM, Zhang C, Ramonell K (1995) A novel metabotropic glutamate receptor expressed in the retina and olfactory bulb. J Neurosci 15: 3075-3083
Dwight JF, Hendry BM (1995) Actions of arachidonic acid on erythrocyte membrane Rb permeability. Clin Chim Acta 238: 187-197
Dyck B, Goodfellow VS, Phillips T, Grey J, Haddach M, Rowbottom M, Naeve GS, Brown B, Saunders J (2004) Potent imidazole and triazole CB1 receptor antagonists related to SR141716. Bioorg Med Chem Lett 14: 1151-1154
Dyson S, Gurdon JB (1997) Activin signalling has a necessary function in Xenopus early development. Curr Biol 7: 81-84
Dzeja PP, Bast P, Ozcan C, Valverde A, Holmuhamedov EL, Van Wylen DG, Terzic A (2003) Targeting nucleotide-requiring enzymes: implications for diazoxide-induced cardioprotection. Am J Physiol Heart Circ Physiol 284: H1048-1056